{
    "Trade/Device Name(s)": [
        "Hitachi Clinical Analyzer S TEST Reagent Cartridge Cholesterol (CHO)",
        "Hitachi Clinical Analyzer S TEST Reagent Cartridge High Density Lipoprotein Cholesterol (HDL)",
        "Hitachi Clinical Analyzer S TEST Reagent Cartridge Low Density Lipoprotein Cholesterol (LDL)",
        "Hitachi Clinical Analyzer S TEST Reagent Cartridge Triglycerides (TG)"
    ],
    "Submitter Information": "Hitachi Chemical Diagnostics, Inc.",
    "510(k) Number": "K111753",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060373",
        "K031824",
        "K033610",
        "K012287",
        "K972250",
        "K091413"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "CDT",
        "CHH",
        "LBS",
        "MRR",
        "JE"
    ],
    "Summary Letter Date": "December 9, 2011",
    "Summary Letter Received Date": "December 12, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1175",
        "21CFR862.1475",
        "21CFR862.1705"
    ],
    "Regulation Name(s)": [
        "Cholesterol (total) test system",
        "Lipoprotein (HDL, LDL) test system",
        "Triglyceride test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cholesterol",
        "High Density Lipoprotein Cholesterol",
        "Low Density Lipoprotein Cholesterol",
        "Triglycerides"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Heparinized plasma"
    ],
    "Specimen Container(s)": [
        "Sample cup"
    ],
    "Instrument(s)/Platform(s)": [
        "Hitachi Clinical Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic method",
        "Enzymatic direct method",
        "Colorimetric detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Cartridge",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for Hitachi Clinical Analyzer S TEST reagent cartridges for measurement of cholesterol, HDL, LDL, and triglycerides using enzymatic and colorimetric methods.",
    "Indications for Use Summary": "Intended for quantitative measurement of cholesterol, HDL, LDL, and triglycerides in serum or heparinized plasma for diagnosis and treatment of disorders of lipid and lipoprotein metabolism in clinical laboratories or physician office laboratories.",
    "fda_folder": "Clinical Chemistry"
}